The company, which has seen its share price shoot up to 277p since floating on the London Stock Exchange at 210p at the end of July, said the growth had been driven by a 9.2% rise in inpatient and daycase discharge volumes to approximately 128,000.Adjusted EBITDA was up 9.3% on 2013 at £79.9m while operating…
Join thousands of sector professionals
©2026 All rights reserved LaingBuisson

